Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Navan Inc. Class A Common Stock (NAVN) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance

Navan Inc. Class A Common StockTrade
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Trade

Price performance (Past 24H)

Key statistics

Navan Inc. Class A Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.72 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 9.8× Navan Inc. Class A Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Navan Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.

NAVNTAK
Market Cap
$6.01B$58.74B
Volume
2,990,4253,110,994
Sector
TechnologyHealth
52-Week High
$30.58$19.05
52-Week Low
$8.51$13.23
Typical Hold Time
1 Days1 Days
Enterprise Value
$5.36B$86.65B
Dividend Yield
—3.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Navan Inc. Class A Common Stock

Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.

Read more on NAVN →

About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.

Read more on TAK →